This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing Ex-Vivo (cell based) Gene Therapy.

About

Ex-vivo gene therapy medicinal products are ATMPs, which require pharmacy oversight, even when being handled elsewhere within a healthcare organisation.

Purpose

The purpose of this document is to outline the key areas where chief pharmacists should focus pharmaceutical expertise prior to an organisation implementing any ex-vivo (cell based) Gene Therapy Medicinal Product (GTMP).

This document presents a flow diagram outlining a stepwise approach to implementing processes to prepare and administer ex-vivo (cell based) GTMP. It is followed by checklists which relate to the various steps presented in the diagram

Attachments

Print this page